Cardiff Oncology, Inc. (CRDF) Dividend History

Company News

• Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

  The global cancer market is projected to surpass $900 billion by 2034, driven by advancements in cancer treatments from biotech companies like Oncolytics Biotech, Exelixis, Cardiff Oncology, ALX Oncology, and Verastem.

  Benzinga

  Featured Companies: ALXO EXEL ONCY VSTM
• Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial

  Cardiff Oncology announced positive initial data from a randomized Phase 2 trial evaluating onvansertib in combination with standard-of-care in patients with first-line RAS-mutated metastatic colorectal cancer. The 30mg dose of onvansertib demonstrated a 64% objective response rate, significantly higher than the 33% rate in the control arm.

  GlobeNewswire Inc.
• Take the Zacks Approach to Beat the Markets: Navios Maritime, Coinbase Global, Virtu Financial in Focus

  Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

  Zacks Investment Research

  Featured Companies: AXON AZO CHD COIN GIS HRL NMM NOBL NVDA TOL VIRT
• Finding Long Term Penny Stocks Investments? 3 Tips

  Here's 3 top tips for investing in penny stocks in the long term The post Finding Long Term Penny Stocks Investments? 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: ADIL MTC
• Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks

  Costco shares dipped in premarket trading on Wednesday, alongside TrueCar and Morphic Holdings. On the upside, Cardiff Oncology and MillerKnoll shares surged.

  MarketWatch

  Featured Companies: COST MLKN PRGS TRUE